MB
MBX Bio
MBX·NASDAQCarmel INFounded 202030 employees
Small CapbiotechPublicEndocrinologyRare Disease
Platform: GLP-1R Rare
Market Cap
$0.6B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (MBX)
Loading MBX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lirasacituzumab | MBX-9111 | Preclinical | 1 | PCSK9 | ADPKDIgAN | ||
| MBX-6478 | MBX-6478 | Phase 1/2 | 2 | MET | TTR AmyloidosisNSCLC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)